RU94022480A - Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с - Google Patents

Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с

Info

Publication number
RU94022480A
RU94022480A RU94022480/14A RU94022480A RU94022480A RU 94022480 A RU94022480 A RU 94022480A RU 94022480/14 A RU94022480/14 A RU 94022480/14A RU 94022480 A RU94022480 A RU 94022480A RU 94022480 A RU94022480 A RU 94022480A
Authority
RU
Russia
Prior art keywords
hepatitis
treatment
virus
preparation
composition enhancing
Prior art date
Application number
RU94022480/14A
Other languages
English (en)
Other versions
RU2104010C1 (ru
Inventor
Кретьен Поль
Us]
Мучник Мильтон
Е.Шерман Кеннет
Original Assignee
Альфа I биомедикалз
Альфа I биомедикалз, Инк.
Инк. (US)
Мучник Мильтон
Мильтон Мучник (US)
Е.Шерман Кеннет
Кеннет Е.Шерман (US)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Альфа I биомедикалз, Альфа I биомедикалз, Инк., Инк. (US), Мучник Мильтон, Мильтон Мучник (US), Е.Шерман Кеннет, Кеннет Е.Шерман (US) filed Critical Альфа I биомедикалз
Publication of RU94022480A publication Critical patent/RU94022480A/ru
Application granted granted Critical
Publication of RU2104010C1 publication Critical patent/RU2104010C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Abstract

В заявке раскрываются композиции и способы лечения млекопитающих, зараженных вирусом С. Композиции включают только один или несколько тимозинов или в комбинации с одним или несколькими интерферонами. Способы лечения включают использование одних только тимозинов или вместе или последовательно с интерфероном.

Claims (1)

  1. В заявке раскрываются композиции и способы лечения млекопитающих, зараженных вирусом С. Композиции включают только один или несколько тимозинов или в комбинации с одним или несколькими интерферонами. Способы лечения включают использование одних только тимозинов или вместе или последовательно с интерфероном.
RU94022480A 1991-09-13 1992-09-08 Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с RU2104010C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75954491A 1991-09-13 1991-09-13
US759,544 1991-09-13
US759544 1991-09-13
PCT/US1992/007556 WO1993005806A1 (en) 1991-09-13 1992-09-08 Composition and method of treating hepatitis c

Publications (2)

Publication Number Publication Date
RU94022480A true RU94022480A (ru) 1996-07-20
RU2104010C1 RU2104010C1 (ru) 1998-02-10

Family

ID=25056052

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94022480A RU2104010C1 (ru) 1991-09-13 1992-09-08 Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с

Country Status (23)

Country Link
US (3) US6001799A (ru)
EP (1) EP0603305B1 (ru)
JP (1) JP3228512B2 (ru)
KR (1) KR100254082B1 (ru)
AT (1) ATE152914T1 (ru)
AU (1) AU667327B2 (ru)
CA (1) CA2119006C (ru)
CZ (1) CZ286827B6 (ru)
DE (1) DE69219782T2 (ru)
DK (1) DK0603305T3 (ru)
ES (1) ES2103966T3 (ru)
FI (1) FI107879B (ru)
GR (1) GR3024025T3 (ru)
HK (1) HK1021687A1 (ru)
HU (1) HU221006B1 (ru)
MX (1) MX9205240A (ru)
NO (1) NO941310L (ru)
RO (1) RO111991B1 (ru)
RU (1) RU2104010C1 (ru)
SG (1) SG64897A1 (ru)
TW (1) TW224053B (ru)
WO (1) WO1993005806A1 (ru)
ZA (1) ZA926964B (ru)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW224053B (ru) * 1991-09-13 1994-05-21 Paul B Chretien
SG64892A1 (en) * 1992-02-06 1999-05-25 Sciclone Pharmaceuticals Method for treating hepatitis b carriers with minimal disease
WO1994001125A1 (en) * 1992-07-13 1994-01-20 Sherman Kenneth E Composition and method of treating hepatitis b
AU751199B2 (en) * 1992-07-13 2002-08-08 Government Of The United States Of America As Represented By The Secretary Of The Army Composition and method of treating hepatitis B
CN1072961C (zh) * 1993-03-05 2001-10-17 施塞克龙药品公司 治疗对干扰素治疗无反应者的丙型肝炎的方法
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
TW249754B (ru) * 1993-10-26 1995-06-21 Alpha I Biomedicals Inc
MXPA94003453A (es) * 1993-11-05 2004-08-16 Alpha 1 Biomedicals Inc Metodo y composicion para el tratamiento de pacientes con hepatitis b que tienen descompensacion hepatica.
JP3837769B2 (ja) * 1995-06-12 2006-10-25 大塚製薬株式会社 抗ウイルス剤
GEP20012489B (en) * 1996-02-28 2001-07-25 Ifi Inst Farmacoterapico Italiano S P A Use of Natural Human α-Interferon
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CN1315862C (zh) 2000-05-26 2007-05-16 艾登尼科斯（开曼）有限公司 处理黄病毒和瘟病毒的方法和组合物
US7208167B2 (en) * 2000-08-07 2007-04-24 Sciclone Pharmaceuticals, Inc. Treatment of hepatitis C with thymosin and peptide combination therapy
MXPA03001145A (es) * 2000-08-07 2004-08-02 Sciclone Pharmaceuticals Inc Composicion farmaceutica para el tratamiento de la hepatitis c con timocina, interferon y ribavirin.
US6878364B2 (en) * 2000-12-01 2005-04-12 Cornell Research Foundation, Inc. Animal model for flaviviridae infection
US7138376B2 (en) * 2001-09-28 2006-11-21 Idenix Pharmaceuticals, Inc. Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides
HUP0600449A2 (en) * 2001-10-05 2006-09-28 Intermune Methods of treating liver fibrosis and hepatitis c virus infection
UA81613C2 (ru) * 2001-10-26 2008-01-25 Род Айленд Хоспитл Стимуляция тимозином генетической иммунизации
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
JP2005522443A (ja) * 2002-02-14 2005-07-28 フアーマセツト・リミテツド 改変フッ素化ヌクレオシド類似体
CN103319554A (zh) 2002-06-28 2013-09-25 埃迪尼克斯医药公司 用于治疗黄病毒感染的修饰的2’和3’-核苷前药
NZ537662A (en) 2002-06-28 2007-10-26 Idenix Cayman Ltd 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
US7456155B2 (en) 2002-06-28 2008-11-25 Idenix Pharmaceuticals, Inc. 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
EP1576138B1 (en) 2002-11-15 2017-02-01 Idenix Pharmaceuticals LLC. 2'-methyl nucleosides in combination with interferon and flaviviridae mutation
KR20050109918A (ko) 2002-12-12 2005-11-22 이데닉스 (케이만) 리미티드 2'-분지형 뉴클레오시드의 제조 방법
GB0301879D0 (en) * 2003-01-27 2003-02-26 Regent Res Llp HCV combination therapy
JP4149296B2 (ja) * 2003-03-26 2008-09-10 株式会社ルネサステクノロジ 半導体記憶装置
ATE467422T1 (de) * 2003-03-28 2010-05-15 Sciclone Pharmaceuticals Inc Behandlung von aspergillus-infektionen mit thymosin alpha 1
CN100342907C (zh) * 2003-03-28 2007-10-17 希克龙制药公司 胸腺素α1在制备用于治疗或预防哺乳动物中曲霉菌感染的药物组合物中的应用
US20100311656A1 (en) * 2003-04-23 2010-12-09 Sciclone Pharmaceuticals, Inc. Treatment or prevention of respiratory viral infections with alpha thymosin peptides
ES2726998T3 (es) 2003-05-30 2019-10-11 Gilead Pharmasset Llc Análogos de nucleósidos fluorados modificados
RU2006105640A (ru) * 2003-07-25 2007-09-10 Айденикс (Кайман) Лимитед (Ky) Аналоги пуриновых нуклеозидов для лечения flaviviridae, включая гепатит с
WO2005021007A1 (fr) * 2003-08-28 2005-03-10 Obschestvo S Ogranichennoi Otvetstvennostju 'berezovy Mir' Prevention et traitement de l'hepatite virale b
WO2005107742A1 (en) 2004-05-05 2005-11-17 Yale University Novel antiviral helioxanthin analogs
CN101023094B (zh) 2004-07-21 2011-05-18 法莫赛特股份有限公司 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
NZ554442A (en) 2004-09-14 2011-05-27 Pharmasset Inc Preparation of 2'fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
JP4516863B2 (ja) * 2005-03-11 2010-08-04 株式会社ケンウッド 音声合成装置、音声合成方法及びプログラム
EP1976382B1 (en) 2005-12-23 2013-04-24 IDENIX Pharmaceuticals, Inc. Process for preparing a synthetic intermediate for preparation of branched nucleosides
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
EP2012816B1 (en) * 2006-05-02 2012-06-27 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Use of thymosin 1, alone or in combination with ptx3 or ganciclovir, for the treatment of cytomegalovirus infection
ES2288118B1 (es) * 2006-05-10 2008-11-01 Bcn Peptides, S.A. Procedimiento para sintetizar timosinas.
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) * 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
US20110195048A1 (en) * 2008-10-08 2011-08-11 Podack Eckhard R Regulation of lymphocytes and uses therefor
CN102325783A (zh) 2008-12-23 2012-01-18 法莫赛特股份有限公司 嘌呤核苷的合成
CA2748034A1 (en) 2008-12-23 2010-07-01 Pharmasset, Inc. Purified 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate prodrugs for the treatment of viral infections
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
WO2010129947A2 (en) 2009-05-08 2010-11-11 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI576352B (zh) * 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
SG184323A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasett Llc Stereoselective synthesis of phosphorus containing actives
US8563530B2 (en) 2010-03-31 2013-10-22 Gilead Pharmassel LLC Purine nucleoside phosphoramidate
CA2818853A1 (en) 2010-11-30 2012-06-07 Gilead Pharmasset Llc 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
US8809354B2 (en) 2011-12-31 2014-08-19 Sheikh Riazuddin 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
CN103800293B (zh) * 2012-11-09 2015-10-21 长春海悦药业有限公司 一种含有胸腺法新的药物组合物及其制剂
PL3038601T3 (pl) 2013-08-27 2020-08-24 Gilead Pharmasset Llc Formulacja złożona dwóch związków przeciwwirusowych

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216056B (it) * 1988-03-11 1990-02-22 Sclavo Spa Composizioni farmaceutiche contenenti timosina alfa 1.
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
TW224053B (ru) * 1991-09-13 1994-05-21 Paul B Chretien

Also Published As

Publication number Publication date
JPH06510998A (ja) 1994-12-08
HK1021687A1 (en) 2000-06-23
RU2104010C1 (ru) 1998-02-10
DE69219782T2 (de) 1997-10-09
US5849696A (en) 1998-12-15
CA2119006A1 (en) 1993-04-01
NO941310D0 (no) 1994-04-12
FI107879B (fi) 2001-10-31
HU9400758D0 (en) 1994-06-28
DE69219782D1 (de) 1997-06-19
KR100254082B1 (ko) 2000-09-01
AU667327B2 (en) 1996-03-21
NO941310L (no) 1994-04-12
CZ286827B6 (cs) 2000-07-12
US6001799A (en) 1999-12-14
HU221006B1 (hu) 2002-07-29
JP3228512B2 (ja) 2001-11-12
MX9205240A (es) 1993-07-01
US20070218033A1 (en) 2007-09-20
ATE152914T1 (de) 1997-05-15
DK0603305T3 (da) 1997-09-01
WO1993005806A1 (en) 1993-04-01
RO111991B1 (ro) 1997-04-30
FI941133A0 (fi) 1994-03-10
ES2103966T3 (es) 1997-10-01
CZ55194A3 (en) 1994-10-19
GR3024025T3 (en) 1997-10-31
CA2119006C (en) 2005-08-23
SG64897A1 (en) 1999-05-25
ZA926964B (en) 1993-04-26
EP0603305B1 (en) 1997-05-14
FI941133A (fi) 1994-03-10
TW224053B (ru) 1994-05-21
HUT75166A (en) 1997-04-28
EP0603305A1 (en) 1994-06-29
AU2644792A (en) 1993-04-27

Similar Documents

Publication Publication Date Title
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
EA199901031A1 (ru) Производные бензимидазола
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
EA199700215A1 (ru) Защита от вирусных инфекций путем колонизации слизистых оболочек генетически модифицированными бактериями
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
IL87621A0 (en) Conjugates of cytokines with immunoglobulins,their preparation and pharmaceutical compositions containing them
ATE236271T1 (de) Verwendung der ndv zur herstellung eines medikaments zur krebsbehandlung
DE69130071T2 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
ATE175873T1 (de) Weitere indolderivate mit antiviraler wirkung
ATE232394T1 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
ATE205881T1 (de) Pharmazeutische zusammensetzung gegen durch papillomaviren verursachte tumoren und infektionen
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
MX9304209A (es) Composicion y metodo de tratamiento de hepatitis b.
DE3751772T2 (de) Impfstoff zur behandlung von hsv
KR960700741A (ko) 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment)
ATE155795T1 (de) Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier
DE69210737T2 (de) Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
DE69006187D1 (de) Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren.
EA200000011A1 (ru) Средства и способы доставки лекарственных препаратов для терапии вирусных и бактериальных инфекций и синдромов истощения
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
MY110041A (en) Composition and method of treating hepatitis c
MXPA94003453A (es) Metodo y composicion para el tratamiento de pacientes con hepatitis b que tienen descompensacion hepatica.
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви